| 0 |
EROSIVE PUSTULAR DERMATOSIS |
20 |
0.4000 |
| 1 |
PSEUDOCELLULITIS |
69 |
0.3224 |
| 2 |
SCLEROEDEMA |
12 |
0.2069 |
| 3 |
HETEROPLASIA |
8 |
0.2051 |
| 4 |
BRAIN RADIATION NECROSIS |
13 |
0.1757 |
| 5 |
LUNG ADENOCARCINOMA RECURRENT |
15 |
0.1456 |
| 6 |
FLAGELLATE DERMATITIS |
9 |
0.1385 |
| 7 |
BRAF V600E MUTATION POSITIVE |
8 |
0.1311 |
| 8 |
MENINGITIS NONINFECTIVE |
8 |
0.1270 |
| 9 |
MALIGNANT NEOPLASM OLIGOPROGRESSION |
25 |
0.1256 |
| 10 |
AUTOIMMUNE LUNG DISEASE |
14 |
0.1186 |
| 11 |
EGFR GENE MUTATION |
44 |
0.1176 |
| 12 |
IMMUNE-MEDIATED OESOPHAGITIS |
8 |
0.1111 |
| 13 |
SCLERODERMA-LIKE REACTION |
17 |
0.1076 |
| 14 |
LUNG ADENOCARCINOMA STAGE IV |
38 |
0.0997 |
| 15 |
ENDOCRINE TOXICITY |
9 |
0.0882 |
| 16 |
BILIRUBINURIA |
9 |
0.0857 |
| 17 |
IMMUNE-MEDIATED LUNG DISEASE |
156 |
0.0855 |
| 18 |
HYPERPHOSPHATURIA |
10 |
0.0855 |
| 19 |
K-RAS GENE MUTATION |
9 |
0.0849 |
| 20 |
TRACHEAL FISTULA |
13 |
0.0844 |
| 21 |
NON-SMALL CELL LUNG CANCER METASTATIC |
70 |
0.0796 |
| 22 |
MYOCARDITIS-MYOSITIS-MYASTHENIA GRAVIS OVERLAP SYNDROME |
17 |
0.0746 |
| 23 |
NON-SMALL CELL LUNG CANCER |
357 |
0.0745 |
| 24 |
IMMUNE-MEDIATED DERMATITIS |
75 |
0.0744 |
| 25 |
LEUKAEMIA CUTIS |
11 |
0.0714 |
| 26 |
MALIGNANT TRANSFORMATION |
32 |
0.0713 |
| 27 |
NON-SMALL CELL LUNG CANCER RECURRENT |
19 |
0.0671 |
| 28 |
NECROTIC LYMPHADENOPATHY |
8 |
0.0667 |
| 29 |
ACQUIRED GENE MUTATION |
86 |
0.0656 |
| 30 |
IMMUNE-MEDIATED NEUROPATHY |
10 |
0.0645 |
| 31 |
IMMUNE-MEDIATED ARTHRITIS |
24 |
0.0630 |
| 32 |
IMMUNE-MEDIATED GASTRITIS |
12 |
0.0625 |
| 33 |
DRUG RESISTANCE MUTATION |
11 |
0.0618 |
| 34 |
MICROVASCULAR CORONARY ARTERY DISEASE |
12 |
0.0558 |
| 35 |
AUTOIMMUNE NEPHRITIS |
12 |
0.0545 |
| 36 |
AUTOIMMUNE DERMATITIS |
8 |
0.0530 |
| 37 |
IMMUNE-MEDIATED CHOLANGITIS |
19 |
0.0529 |
| 38 |
IMMUNE-MEDIATED HYPOTHYROIDISM |
59 |
0.0523 |
| 39 |
NON-SMALL CELL LUNG CANCER STAGE IV |
19 |
0.0521 |
| 40 |
DERMO-HYPODERMITIS |
31 |
0.0520 |
| 41 |
DIABETIC KETOACIDOTIC HYPERGLYCAEMIC COMA |
9 |
0.0495 |
| 42 |
IMMUNE-MEDIATED NEPHRITIS |
23 |
0.0490 |
| 43 |
IMMUNE-MEDIATED HEPATITIS |
100 |
0.0489 |
| 44 |
TUMOUR PSEUDOPROGRESSION |
51 |
0.0466 |
| 45 |
HYPERCREATININAEMIA |
23 |
0.0457 |
| 46 |
LUNG ADENOCARCINOMA |
137 |
0.0455 |
| 47 |
IMMUNE-MEDIATED ENTEROCOLITIS |
167 |
0.0454 |
| 48 |
PLEURAL MESOTHELIOMA MALIGNANT |
14 |
0.0453 |
| 49 |
PLEURAL ADHESION |
9 |
0.0450 |
| 50 |
CANCER FATIGUE |
10 |
0.0420 |
| 51 |
TUMOUR ASSOCIATED FEVER |
17 |
0.0416 |
| 52 |
IMMUNE-MEDIATED RENAL DISORDER |
17 |
0.0411 |
| 53 |
FEBRILE BONE MARROW APLASIA |
174 |
0.0409 |
| 54 |
GLUCOCORTICOID DEFICIENCY |
17 |
0.0402 |
| 55 |
TOXIC ERYTHEMA OF CHEMOTHERAPY |
10 |
0.0386 |
| 56 |
AUTOIMMUNE HYPOTHYROIDISM |
9 |
0.0378 |
| 57 |
IMMUNE-MEDIATED ADRENAL INSUFFICIENCY |
30 |
0.0376 |
| 58 |
XERODERMA |
10 |
0.0375 |
| 59 |
RADIATION NECROSIS |
21 |
0.0366 |
| 60 |
ACUTE INTERSTITIAL PNEUMONITIS |
19 |
0.0364 |
| 61 |
NEONATAL RESPIRATORY DEPRESSION |
12 |
0.0361 |
| 62 |
METASTASES TO ADRENALS |
33 |
0.0358 |
| 63 |
IMMUNE-MEDIATED HYPOPHYSITIS |
16 |
0.0355 |
| 64 |
LUNG ADENOCARCINOMA METASTATIC |
8 |
0.0343 |
| 65 |
CELLULITE |
11 |
0.0337 |
| 66 |
LICHENOID KERATOSIS |
77 |
0.0337 |
| 67 |
SUPERIOR VENA CAVA SYNDROME |
20 |
0.0331 |
| 68 |
SPINAL CORD ABSCESS |
9 |
0.0330 |
| 69 |
PRIMARY ADRENAL INSUFFICIENCY |
10 |
0.0328 |
| 70 |
LYMPHOCYTIC HYPOPHYSITIS |
9 |
0.0326 |
| 71 |
IMMUNE-MEDIATED THYROIDITIS |
16 |
0.0324 |
| 72 |
MYASTHENIC SYNDROME |
25 |
0.0323 |
| 73 |
SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS |
57 |
0.0320 |
| 74 |
METASTASES TO THE MEDIASTINUM |
13 |
0.0316 |
| 75 |
IMMUNE-MEDIATED HYPERTHYROIDISM |
8 |
0.0315 |
| 76 |
IMMUNE-MEDIATED PANCREATITIS |
12 |
0.0315 |
| 77 |
SECONDARY HYPERTENSION |
9 |
0.0315 |
| 78 |
HYPOPHYSITIS |
63 |
0.0313 |
| 79 |
AUTOIMMUNE COLITIS |
20 |
0.0310 |
| 80 |
LYMPHANGIOSIS CARCINOMATOSA |
32 |
0.0307 |
| 81 |
EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED |
38 |
0.0305 |
| 82 |
NEPHRITIS |
100 |
0.0299 |
| 83 |
PEPTIC ULCER PERFORATION |
9 |
0.0298 |
| 84 |
ADRENOCORTICOTROPIC HORMONE DEFICIENCY |
26 |
0.0296 |
| 85 |
BRONCHOPLEURAL FISTULA |
11 |
0.0293 |
| 86 |
BRONCHOSTENOSIS |
16 |
0.0293 |
| 87 |
AORTITIS |
20 |
0.0292 |
| 88 |
OCULAR MYASTHENIA |
10 |
0.0292 |
| 89 |
VISCERAL LEISHMANIASIS |
21 |
0.0291 |
| 90 |
METASTASES TO PLEURA |
30 |
0.0286 |
| 91 |
IMMUNE-MEDIATED HEPATIC DISORDER |
55 |
0.0282 |
| 92 |
MALIGNANT PLEURAL EFFUSION |
47 |
0.0278 |
| 93 |
HYPERAMYLASAEMIA |
15 |
0.0275 |
| 94 |
SYSTEMIC SCLERODERMA |
20 |
0.0275 |
| 95 |
GENE MUTATION |
53 |
0.0268 |
| 96 |
THROMBOPHLEBITIS MIGRANS |
9 |
0.0265 |
| 97 |
RADIATION OESOPHAGITIS |
10 |
0.0262 |
| 98 |
HAEMATOTOXICITY |
248 |
0.0261 |
| 99 |
IMMUNE-MEDIATED MYOCARDITIS |
42 |
0.0260 |
| 100 |
THERAPY PARTIAL RESPONDER |
405 |
0.0259 |
| 101 |
PARONYCHIA |
113 |
0.0257 |
| 102 |
SKIN TOXICITY |
145 |
0.0256 |
| 103 |
OESOPHAGEAL FISTULA |
8 |
0.0252 |
| 104 |
PARANEOPLASTIC SYNDROME |
17 |
0.0251 |
| 105 |
METASTASES TO MENINGES |
56 |
0.0246 |
| 106 |
IMMUNE-MEDIATED ENCEPHALITIS |
13 |
0.0246 |
| 107 |
RADIATION PNEUMONITIS |
51 |
0.0238 |
| 108 |
NEUTROPENIC COLITIS |
46 |
0.0222 |
| 109 |
GRANULOCYTE COUNT INCREASED |
9 |
0.0222 |
| 110 |
IMMUNE-MEDIATED ADVERSE REACTION |
33 |
0.0215 |
| 111 |
BLOOD PHOSPHORUS ABNORMAL |
10 |
0.0212 |
| 112 |
HEPATIC CYTOLYSIS |
267 |
0.0209 |
| 113 |
SECONDARY ADRENOCORTICAL INSUFFICIENCY |
31 |
0.0205 |
| 114 |
HYPOPITUITARISM |
35 |
0.0201 |
| 115 |
RENAL TUBULAR NECROSIS |
197 |
0.0201 |
| 116 |
PNEUMONITIS |
545 |
0.0200 |
| 117 |
NECROTISING MYOSITIS |
17 |
0.0196 |
| 118 |
PULMONARY ARTERY THROMBOSIS |
15 |
0.0195 |
| 119 |
BICYTOPENIA |
38 |
0.0194 |
| 120 |
CANDIDA TEST POSITIVE |
8 |
0.0191 |
| 121 |
STASIS DERMATITIS |
13 |
0.0190 |
| 122 |
TUBULOINTERSTITIAL NEPHRITIS |
356 |
0.0190 |
| 123 |
SUPERINFECTION BACTERIAL |
15 |
0.0189 |
| 124 |
TRACHEO-OESOPHAGEAL FISTULA |
12 |
0.0188 |
| 125 |
HYPERGAMMAGLOBULINAEMIA |
9 |
0.0186 |
| 126 |
RENAL TUBULAR DISORDER |
51 |
0.0181 |
| 127 |
PANCYTOPENIA |
1010 |
0.0181 |
| 128 |
RADIOTHERAPY |
34 |
0.0178 |
| 129 |
HYPERSENSITIVITY PNEUMONITIS |
20 |
0.0176 |
| 130 |
EPIDERMOLYSIS |
8 |
0.0174 |
| 131 |
EXTREMITY NECROSIS |
30 |
0.0172 |
| 132 |
ENTEROCOCCUS TEST POSITIVE |
11 |
0.0170 |
| 133 |
MALIGNANT NEOPLASM PROGRESSION |
1726 |
0.0168 |
| 134 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
217 |
0.0168 |
| 135 |
OTOTOXICITY |
31 |
0.0167 |
| 136 |
SUPERFICIAL VEIN THROMBOSIS |
14 |
0.0166 |
| 137 |
MYELOPROLIFERATIVE NEOPLASM |
11 |
0.0166 |
| 138 |
GASTROINTESTINAL TOXICITY |
79 |
0.0164 |
| 139 |
UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE |
18 |
0.0164 |
| 140 |
HYPERTRANSAMINASAEMIA |
113 |
0.0162 |
| 141 |
ADENOCARCINOMA |
36 |
0.0160 |
| 142 |
ANAL ULCER |
13 |
0.0159 |
| 143 |
FULMINANT TYPE 1 DIABETES MELLITUS |
16 |
0.0155 |
| 144 |
OCULAR TOXICITY |
17 |
0.0154 |
| 145 |
HEART FAILURE WITH REDUCED EJECTION FRACTION |
8 |
0.0150 |
| 146 |
ERYSIPELAS |
75 |
0.0149 |
| 147 |
INTESTINAL PSEUDO-OBSTRUCTION |
13 |
0.0148 |
| 148 |
AORTIC THROMBOSIS |
17 |
0.0147 |
| 149 |
OESOPHAGITIS ULCERATIVE |
10 |
0.0146 |
| 150 |
LYMPHADENOPATHY MEDIASTINAL |
28 |
0.0146 |
| 151 |
METASTASES TO KIDNEY |
8 |
0.0145 |
| 152 |
SYSTEMIC INFECTION |
24 |
0.0145 |
| 153 |
SQUAMOUS CELL CARCINOMA OF LUNG |
11 |
0.0143 |
| 154 |
OVERLAP SYNDROME |
10 |
0.0143 |
| 155 |
DUODENAL PERFORATION |
14 |
0.0143 |
| 156 |
TUMOUR NECROSIS |
15 |
0.0142 |
| 157 |
RENAL TUBULAR INJURY |
17 |
0.0140 |
| 158 |
PULMONARY TOXICITY |
99 |
0.0140 |
| 159 |
URINARY TRACT INFECTION ENTEROCOCCAL |
13 |
0.0139 |
| 160 |
SMALL CELL LUNG CANCER |
21 |
0.0139 |
| 161 |
NEPHROPATHY TOXIC |
155 |
0.0138 |
| 162 |
MEDIASTINITIS |
8 |
0.0138 |
| 163 |
DOSE CALCULATION ERROR |
8 |
0.0137 |
| 164 |
LUNG CANCER METASTATIC |
39 |
0.0135 |
| 165 |
DERMATITIS ACNEIFORM |
82 |
0.0135 |
| 166 |
NEUTROPENIC SEPSIS |
96 |
0.0134 |
| 167 |
ADRENAL ADENOMA |
8 |
0.0134 |
| 168 |
HYDROTHORAX |
11 |
0.0133 |
| 169 |
KIDNEY FIBROSIS |
23 |
0.0132 |
| 170 |
OESOPHAGEAL PERFORATION |
11 |
0.0132 |
| 171 |
HYPERTHYROIDISM |
187 |
0.0129 |
| 172 |
FEBRILE INFECTION |
15 |
0.0127 |
| 173 |
CORNEAL PERFORATION |
8 |
0.0127 |
| 174 |
BONE MARROW TOXICITY |
15 |
0.0127 |
| 175 |
FOETAL EXPOSURE TIMING UNSPECIFIED |
9 |
0.0125 |
| 176 |
EMBOLISM VENOUS |
38 |
0.0125 |
| 177 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
94 |
0.0125 |
| 178 |
EMBOLISM ARTERIAL |
15 |
0.0125 |
| 179 |
MYELOSUPPRESSION |
445 |
0.0123 |
| 180 |
MUCOSAL INFLAMMATION |
322 |
0.0123 |
| 181 |
APLASIA |
24 |
0.0122 |
| 182 |
PALMAR ERYTHEMA |
14 |
0.0121 |
| 183 |
FEBRILE NEUTROPENIA |
799 |
0.0120 |
| 184 |
CARCINOEMBRYONIC ANTIGEN INCREASED |
23 |
0.0119 |
| 185 |
DRUG RESISTANCE |
299 |
0.0116 |
| 186 |
PERFORMANCE STATUS DECREASED |
54 |
0.0116 |
| 187 |
BRONCHIAL CARCINOMA |
9 |
0.0114 |
| 188 |
MIXED LIVER INJURY |
34 |
0.0113 |
| 189 |
GOUTY ARTHRITIS |
9 |
0.0113 |
| 190 |
MYOCARDITIS |
127 |
0.0111 |
| 191 |
ADMINISTRATION SITE EXTRAVASATION |
11 |
0.0110 |
| 192 |
LEUKOCYTURIA |
9 |
0.0109 |
| 193 |
NEPHROSCLEROSIS |
12 |
0.0108 |
| 194 |
N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED |
15 |
0.0107 |
| 195 |
MYOCARDIAL INJURY |
12 |
0.0107 |
| 196 |
ADRENAL INSUFFICIENCY |
129 |
0.0106 |
| 197 |
HYPOALBUMINAEMIA |
81 |
0.0104 |
| 198 |
LUNG CONSOLIDATION |
29 |
0.0104 |
| 199 |
IMMUNE THROMBOCYTOPENIA |
47 |
0.0103 |
| 200 |
CANCER PAIN |
26 |
0.0102 |
| 201 |
HYPERPLASIA |
9 |
0.0100 |
| 202 |
EROSIVE DUODENITIS |
8 |
0.0100 |
| 203 |
MULTIPLE-DRUG RESISTANCE |
31 |
0.0100 |
| 204 |
OESOPHAGITIS |
109 |
0.0100 |
| 205 |
AUTOIMMUNE HAEMOLYTIC ANAEMIA |
34 |
0.0099 |
| 206 |
ADRENAL DISORDER |
19 |
0.0099 |
| 207 |
MONOCYTE COUNT DECREASED |
12 |
0.0098 |
| 208 |
HYPOTHYROIDISM |
312 |
0.0098 |
| 209 |
DISEASE PROGRESSION |
1147 |
0.0097 |
| 210 |
PULMONARY SEPSIS |
14 |
0.0096 |
| 211 |
HEPATOTOXICITY |
214 |
0.0096 |
| 212 |
NEOPLASM PROGRESSION |
333 |
0.0096 |
| 213 |
NEPHROGENIC DIABETES INSIPIDUS |
11 |
0.0095 |
| 214 |
INTERSTITIAL LUNG DISEASE |
451 |
0.0093 |
| 215 |
PERIPHERAL ISCHAEMIA |
38 |
0.0093 |
| 216 |
ADRENOCORTICAL INSUFFICIENCY ACUTE |
18 |
0.0092 |
| 217 |
TYPE 1 DIABETES MELLITUS |
55 |
0.0091 |
| 218 |
HILAR LYMPHADENOPATHY |
8 |
0.0091 |
| 219 |
CLOSTRIDIUM COLITIS |
11 |
0.0091 |
| 220 |
SMALL INTESTINAL PERFORATION |
17 |
0.0091 |
| 221 |
ENTERITIS |
58 |
0.0091 |
| 222 |
PHARYNGEAL INFLAMMATION |
11 |
0.0090 |
| 223 |
VANISHING BILE DUCT SYNDROME |
10 |
0.0090 |
| 224 |
LARGE INTESTINE INFECTION |
11 |
0.0089 |
| 225 |
GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE |
10 |
0.0089 |
| 226 |
THROMBOCYTOPENIA |
997 |
0.0089 |
| 227 |
PLEURAL FIBROSIS |
9 |
0.0088 |
| 228 |
PERIPHERAL SENSORIMOTOR NEUROPATHY |
11 |
0.0088 |
| 229 |
COLITIS |
330 |
0.0087 |
| 230 |
MALLORY-WEISS SYNDROME |
11 |
0.0087 |
| 231 |
CHOLANGITIS |
53 |
0.0085 |
| 232 |
RESTRICTIVE PULMONARY DISEASE |
10 |
0.0085 |
| 233 |
METASTASES TO LUNG |
97 |
0.0084 |
| 234 |
LUNG OPACITY |
22 |
0.0083 |
| 235 |
BONE MARROW FAILURE |
169 |
0.0083 |
| 236 |
LISTERIOSIS |
9 |
0.0081 |
| 237 |
ALANINE AMINOTRANSFERASE ABNORMAL |
17 |
0.0081 |
| 238 |
PROTEINURIA |
152 |
0.0080 |
| 239 |
LEUKOPENIA |
398 |
0.0079 |
| 240 |
SUBCLAVIAN VEIN THROMBOSIS |
9 |
0.0079 |
| 241 |
NEUTROPENIA |
1071 |
0.0079 |
| 242 |
PRERENAL FAILURE |
11 |
0.0078 |
| 243 |
AUTOIMMUNE HEPATITIS |
54 |
0.0078 |
| 244 |
ARTERIAL THROMBOSIS |
15 |
0.0078 |
| 245 |
DACRYOSTENOSIS ACQUIRED |
10 |
0.0077 |
| 246 |
TRANSITIONAL CELL CARCINOMA |
10 |
0.0077 |
| 247 |
METASTASES TO LIVER |
134 |
0.0076 |
| 248 |
ENTEROCOLITIS |
44 |
0.0076 |
| 249 |
IMMUNE-MEDIATED MYOSITIS |
21 |
0.0076 |
| 250 |
POLYARTHRITIS |
40 |
0.0076 |
| 251 |
PNEUMOPERITONEUM |
14 |
0.0076 |
| 252 |
METASTASES TO LYMPH NODES |
51 |
0.0075 |
| 253 |
HEPATITIS |
193 |
0.0075 |
| 254 |
METASTASES TO PERITONEUM |
19 |
0.0075 |
| 255 |
DUODENITIS |
23 |
0.0075 |
| 256 |
BLOOD CHLORIDE DECREASED |
19 |
0.0074 |
| 257 |
THYROIDITIS |
22 |
0.0073 |
| 258 |
HYPOMAGNESAEMIA |
101 |
0.0072 |
| 259 |
ESCHERICHIA BACTERAEMIA |
17 |
0.0072 |
| 260 |
ASPARTATE AMINOTRANSFERASE ABNORMAL |
11 |
0.0072 |
| 261 |
VASCULAR PURPURA |
10 |
0.0072 |
| 262 |
RASH MACULO-PAPULAR |
159 |
0.0071 |
| 263 |
METASTASIS |
51 |
0.0071 |
| 264 |
STAPHYLOCOCCUS TEST POSITIVE |
15 |
0.0071 |
| 265 |
TOXIC EPIDERMAL NECROLYSIS |
108 |
0.0071 |
| 266 |
DIABETES INSIPIDUS |
17 |
0.0071 |
| 267 |
ANAEMIA MACROCYTIC |
15 |
0.0070 |
| 268 |
METASTASES TO BONE |
115 |
0.0070 |
| 269 |
EMBOLISM |
58 |
0.0070 |
| 270 |
LARGE INTESTINE PERFORATION |
48 |
0.0069 |
| 271 |
DERMATITIS EXFOLIATIVE GENERALISED |
24 |
0.0069 |
| 272 |
ANAEMIA |
1313 |
0.0069 |
| 273 |
INFLAMMATORY MARKER INCREASED |
34 |
0.0069 |
| 274 |
PERIPHERAL SENSORY NEUROPATHY |
40 |
0.0068 |
| 275 |
TUMOUR PAIN |
9 |
0.0068 |
| 276 |
ISCHAEMIA |
31 |
0.0067 |
| 277 |
CYTOPENIA |
82 |
0.0067 |
| 278 |
SUSPECTED OFF LABEL USE |
30 |
0.0066 |
| 279 |
NON-CARDIAC CHEST PAIN |
21 |
0.0066 |
| 280 |
VENA CAVA THROMBOSIS |
11 |
0.0066 |
| 281 |
PANNICULITIS |
16 |
0.0066 |
| 282 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
63 |
0.0066 |
| 283 |
EMPYEMA |
13 |
0.0065 |
| 284 |
HYPERPHOSPHATAEMIA |
14 |
0.0065 |
| 285 |
DERMATITIS BULLOUS |
47 |
0.0065 |
| 286 |
PERIPHERAL MOTOR NEUROPATHY |
9 |
0.0064 |
| 287 |
CULTURE URINE POSITIVE |
9 |
0.0064 |
| 288 |
VENOUS THROMBOSIS |
25 |
0.0064 |
| 289 |
PERIORBITAL OEDEMA |
33 |
0.0063 |
| 290 |
HYPOCALCAEMIA |
119 |
0.0063 |
| 291 |
HAEMOPTYSIS |
175 |
0.0063 |
| 292 |
CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY |
9 |
0.0063 |
| 293 |
PERICARDIAL EFFUSION |
144 |
0.0062 |
| 294 |
POLYMYOSITIS |
11 |
0.0062 |
| 295 |
MUTISM |
9 |
0.0062 |
| 296 |
HEPATITIS TOXIC |
16 |
0.0061 |
| 297 |
METASTATIC NEOPLASM |
26 |
0.0060 |
| 298 |
PLEURAL EFFUSION |
364 |
0.0060 |
| 299 |
HEPATITIS CHOLESTATIC |
36 |
0.0060 |
| 300 |
DUODENAL ULCER HAEMORRHAGE |
17 |
0.0059 |
| 301 |
KERATITIS |
18 |
0.0059 |
| 302 |
NEOPLASM RECURRENCE |
20 |
0.0059 |
| 303 |
CARDIAC TAMPONADE |
28 |
0.0059 |
| 304 |
BRAIN NATRIURETIC PEPTIDE INCREASED |
18 |
0.0058 |
| 305 |
NEUTROPHIL COUNT DECREASED |
237 |
0.0058 |
| 306 |
GASTROINTESTINAL PERFORATION |
24 |
0.0058 |
| 307 |
TOXIC SKIN ERUPTION |
58 |
0.0058 |
| 308 |
SPLENIC INFARCTION |
10 |
0.0057 |
| 309 |
HEPATITIS ACUTE |
37 |
0.0057 |
| 310 |
ENCEPHALITIS |
39 |
0.0056 |
| 311 |
DYSAESTHESIA |
17 |
0.0055 |
| 312 |
CYTOKINE RELEASE SYNDROME |
111 |
0.0055 |
| 313 |
ACUTE KIDNEY INJURY |
840 |
0.0055 |
| 314 |
ATELECTASIS |
53 |
0.0055 |
| 315 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
55 |
0.0055 |
| 316 |
RHEUMATOID NODULE |
15 |
0.0054 |
| 317 |
NORMOCYTIC ANAEMIA |
8 |
0.0054 |
| 318 |
CAPILLARY LEAK SYNDROME |
11 |
0.0053 |
| 319 |
INTERVERTEBRAL DISCITIS |
10 |
0.0053 |
| 320 |
PNEUMOTHORAX |
84 |
0.0053 |
| 321 |
BLOOD THYROID STIMULATING HORMONE DECREASED |
24 |
0.0053 |
| 322 |
HYPOPROTEINAEMIA |
10 |
0.0053 |
| 323 |
GRANULOCYTOPENIA |
30 |
0.0053 |
| 324 |
MANTLE CELL LYMPHOMA |
8 |
0.0053 |
| 325 |
HYPOKALAEMIA |
242 |
0.0052 |
| 326 |
SCLERODERMA |
19 |
0.0052 |
| 327 |
SEPTIC SHOCK |
227 |
0.0052 |
| 328 |
CUTANEOUS VASCULITIS |
19 |
0.0052 |
| 329 |
TRAUMATIC LUNG INJURY |
10 |
0.0052 |
| 330 |
HAEMOTHORAX |
15 |
0.0052 |
| 331 |
GENERAL PHYSICAL HEALTH DETERIORATION |
589 |
0.0051 |
| 332 |
FUNGAEMIA |
8 |
0.0051 |
| 333 |
JUGULAR VEIN THROMBOSIS |
9 |
0.0051 |
| 334 |
CACHEXIA |
26 |
0.0050 |
| 335 |
CHOLESTASIS |
97 |
0.0050 |
| 336 |
HICCUPS |
41 |
0.0050 |
| 337 |
BONE LESION |
18 |
0.0050 |
| 338 |
NEUTROPHIL COUNT ABNORMAL |
14 |
0.0049 |
| 339 |
INTESTINAL ISCHAEMIA |
27 |
0.0049 |
| 340 |
RESPIRATORY FAILURE |
355 |
0.0049 |
| 341 |
PULMONARY HAEMORRHAGE |
38 |
0.0049 |
| 342 |
TRANSAMINASES INCREASED |
108 |
0.0049 |
| 343 |
IDIOPATHIC PULMONARY FIBROSIS |
19 |
0.0048 |
| 344 |
PULMONARY EMBOLISM |
455 |
0.0048 |
| 345 |
POLYNEUROPATHY |
57 |
0.0048 |
| 346 |
ORAL FUNGAL INFECTION |
13 |
0.0047 |
| 347 |
POLYMYALGIA RHEUMATICA |
15 |
0.0047 |
| 348 |
ERYTHEMA MULTIFORME |
44 |
0.0047 |
| 349 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
18 |
0.0047 |
| 350 |
CARDIOTOXICITY |
42 |
0.0047 |
| 351 |
LEFT VENTRICULAR DYSFUNCTION |
31 |
0.0046 |
| 352 |
PYELONEPHRITIS ACUTE |
9 |
0.0046 |
| 353 |
BLOOD ALBUMIN DECREASED |
36 |
0.0045 |
| 354 |
APLASTIC ANAEMIA |
23 |
0.0044 |
| 355 |
HAEMOLYTIC ANAEMIA |
39 |
0.0043 |
| 356 |
INFUSION RELATED REACTION |
288 |
0.0043 |
| 357 |
ISCHAEMIC STROKE |
77 |
0.0043 |
| 358 |
LICHEN PLANUS |
10 |
0.0043 |
| 359 |
HEPATOCELLULAR INJURY |
61 |
0.0043 |
| 360 |
VITILIGO |
10 |
0.0043 |
| 361 |
BLOOD CREATININE INCREASED |
278 |
0.0043 |
| 362 |
HEPATIC FUNCTION ABNORMAL |
158 |
0.0042 |
| 363 |
URINARY TRACT OBSTRUCTION |
10 |
0.0042 |
| 364 |
METASTASES TO SPINE |
14 |
0.0042 |
| 365 |
HEPATIC LESION |
18 |
0.0042 |
| 366 |
AGRANULOCYTOSIS |
77 |
0.0041 |
| 367 |
DYSPNOEA AT REST |
12 |
0.0041 |
| 368 |
ESCHERICHIA SEPSIS |
12 |
0.0041 |
| 369 |
MYOSITIS |
37 |
0.0041 |
| 370 |
RENAL IMPAIRMENT |
346 |
0.0041 |
| 371 |
CUTANEOUS LUPUS ERYTHEMATOSUS |
8 |
0.0041 |
| 372 |
CORNEAL DISORDER |
9 |
0.0041 |
| 373 |
STOMATITIS |
247 |
0.0041 |
| 374 |
BLOOD CREATINE INCREASED |
18 |
0.0041 |
| 375 |
CUSHINGOID |
13 |
0.0040 |
| 376 |
LIP OEDEMA |
17 |
0.0040 |
| 377 |
PERSECUTORY DELUSION |
10 |
0.0040 |
| 378 |
INTESTINAL PERFORATION |
45 |
0.0040 |
| 379 |
THROMBOTIC THROMBOCYTOPENIC PURPURA |
14 |
0.0040 |
| 380 |
VASCULITIS |
46 |
0.0039 |
| 381 |
DERMATOMYOSITIS |
10 |
0.0039 |
| 382 |
DRUG-INDUCED LIVER INJURY |
123 |
0.0039 |
| 383 |
DRUG TOLERANCE DECREASED |
11 |
0.0039 |
| 384 |
TUMOUR HAEMORRHAGE |
11 |
0.0039 |
| 385 |
RASH PUSTULAR |
28 |
0.0038 |
| 386 |
ASPARTATE AMINOTRANSFERASE INCREASED |
203 |
0.0038 |
| 387 |
SMALL INTESTINAL OBSTRUCTION |
47 |
0.0038 |
| 388 |
HYPERPYREXIA |
16 |
0.0038 |
| 389 |
LUNG INFILTRATION |
33 |
0.0037 |
| 390 |
HYPONATRAEMIA |
209 |
0.0037 |
| 391 |
TROPONIN INCREASED |
28 |
0.0037 |
| 392 |
ATYPICAL PNEUMONIA |
11 |
0.0037 |
| 393 |
GLOMERULONEPHRITIS |
9 |
0.0037 |
| 394 |
PERIPHERAL ARTERIAL OCCLUSIVE DISEASE |
15 |
0.0037 |
| 395 |
DRUG ERUPTION |
65 |
0.0037 |
| 396 |
RENAL FUNCTION TEST ABNORMAL |
17 |
0.0037 |
| 397 |
ORGANISING PNEUMONIA |
18 |
0.0036 |
| 398 |
OPTIC ISCHAEMIC NEUROPATHY |
14 |
0.0036 |
| 399 |
SECOND PRIMARY MALIGNANCY |
30 |
0.0036 |
| 400 |
TACHYARRHYTHMIA |
9 |
0.0036 |
| 401 |
PLATELET COUNT DECREASED |
377 |
0.0035 |
| 402 |
ALANINE AMINOTRANSFERASE INCREASED |
216 |
0.0035 |
| 403 |
HYPOPHOSPHATAEMIA |
26 |
0.0035 |
| 404 |
CEREBRAL ISCHAEMIA |
18 |
0.0035 |
| 405 |
LUMBAR VERTEBRAL FRACTURE |
16 |
0.0035 |
| 406 |
TEARFULNESS |
15 |
0.0035 |
| 407 |
APLASIA PURE RED CELL |
12 |
0.0035 |
| 408 |
PNEUMONIA BACTERIAL |
32 |
0.0035 |
| 409 |
HERPES VIRUS INFECTION |
20 |
0.0035 |
| 410 |
FAECALOMA |
19 |
0.0035 |
| 411 |
HYPOXIC-ISCHAEMIC ENCEPHALOPATHY |
9 |
0.0034 |
| 412 |
ACUTE RESPIRATORY FAILURE |
66 |
0.0034 |
| 413 |
COLITIS ISCHAEMIC |
23 |
0.0034 |
| 414 |
SUDDEN DEATH |
36 |
0.0034 |
| 415 |
COMPRESSION FRACTURE |
18 |
0.0034 |
| 416 |
C-REACTIVE PROTEIN INCREASED |
122 |
0.0033 |
| 417 |
BRAIN OEDEMA |
42 |
0.0033 |
| 418 |
PHLEBITIS |
17 |
0.0033 |
| 419 |
BONE MARROW DISORDER |
10 |
0.0033 |
| 420 |
TYPE IV HYPERSENSITIVITY REACTION |
9 |
0.0033 |
| 421 |
ELECTROLYTE IMBALANCE |
38 |
0.0033 |
| 422 |
TONGUE ULCERATION |
11 |
0.0033 |
| 423 |
AMYLASE INCREASED |
12 |
0.0032 |
| 424 |
CREATININE RENAL CLEARANCE DECREASED |
13 |
0.0032 |
| 425 |
PROCTITIS |
9 |
0.0032 |
| 426 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
71 |
0.0032 |
| 427 |
IMMUNE THROMBOCYTOPENIC PURPURA |
9 |
0.0032 |
| 428 |
PURPURA |
28 |
0.0032 |
| 429 |
OESOPHAGEAL STENOSIS |
9 |
0.0032 |
| 430 |
SEPSIS |
352 |
0.0032 |
| 431 |
PNEUMATOSIS INTESTINALIS |
9 |
0.0032 |
| 432 |
ASCITES |
92 |
0.0031 |
| 433 |
MENINGITIS ASEPTIC |
14 |
0.0031 |
| 434 |
MEAN CELL VOLUME INCREASED |
8 |
0.0031 |
| 435 |
GENERAL PHYSICAL CONDITION ABNORMAL |
21 |
0.0031 |
| 436 |
APHTHOUS ULCER |
24 |
0.0031 |
| 437 |
CARDIOGENIC SHOCK |
44 |
0.0031 |
| 438 |
NEPHROTIC SYNDROME |
21 |
0.0031 |
| 439 |
DISSEMINATED INTRAVASCULAR COAGULATION |
43 |
0.0031 |
| 440 |
POLYURIA |
25 |
0.0030 |
| 441 |
LUNG NEOPLASM |
13 |
0.0030 |
| 442 |
THORACIC VERTEBRAL FRACTURE |
9 |
0.0030 |
| 443 |
RESPIRATORY TRACT INFECTION |
79 |
0.0030 |
| 444 |
ODYNOPHAGIA |
18 |
0.0030 |
| 445 |
NEUTROPHILIA |
17 |
0.0030 |
| 446 |
HYPOXIA |
105 |
0.0030 |
| 447 |
PATHOLOGICAL FRACTURE |
15 |
0.0030 |
| 448 |
OSTEONECROSIS OF JAW |
73 |
0.0029 |
| 449 |
MALNUTRITION |
33 |
0.0029 |
| 450 |
ENDOCARDITIS |
15 |
0.0029 |
| 451 |
HYPOVOLAEMIC SHOCK |
14 |
0.0029 |
| 452 |
BLOOD CREATININE ABNORMAL |
10 |
0.0029 |
| 453 |
EMPHYSEMA |
29 |
0.0029 |
| 454 |
PULMONARY FIBROSIS |
55 |
0.0029 |
| 455 |
PLEURISY |
17 |
0.0029 |
| 456 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
45 |
0.0028 |
| 457 |
DUODENAL ULCER |
20 |
0.0028 |
| 458 |
JAUNDICE CHOLESTATIC |
10 |
0.0028 |
| 459 |
BLOOD THYROID STIMULATING HORMONE INCREASED |
26 |
0.0028 |
| 460 |
DERMATITIS |
59 |
0.0028 |
| 461 |
MOUTH ULCERATION |
59 |
0.0028 |
| 462 |
SKIN EROSION |
9 |
0.0028 |
| 463 |
DECREASED APPETITE |
645 |
0.0028 |
| 464 |
FLANK PAIN |
26 |
0.0028 |
| 465 |
OESOPHAGEAL CANDIDIASIS |
11 |
0.0028 |
| 466 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
195 |
0.0027 |
| 467 |
PERICARDITIS |
46 |
0.0027 |
| 468 |
ORAL CANDIDIASIS |
36 |
0.0027 |
| 469 |
LIVER INJURY |
67 |
0.0027 |
| 470 |
THROMBOCYTOSIS |
10 |
0.0027 |
| 471 |
RENAL FAILURE |
360 |
0.0027 |
| 472 |
RECURRENT CANCER |
11 |
0.0027 |
| 473 |
PULMONARY MASS |
40 |
0.0027 |
| 474 |
HAEMATOCRIT DECREASED |
53 |
0.0027 |
| 475 |
ARTERIAL OCCLUSIVE DISEASE |
21 |
0.0027 |
| 476 |
BLOOD MAGNESIUM DECREASED |
23 |
0.0027 |
| 477 |
WOUND DEHISCENCE |
9 |
0.0027 |
| 478 |
HEPATIC CYST |
9 |
0.0026 |
| 479 |
AUTOIMMUNE THYROIDITIS |
10 |
0.0026 |
| 480 |
MYOCARDIAL ISCHAEMIA |
30 |
0.0026 |
| 481 |
STAPHYLOCOCCAL SEPSIS |
13 |
0.0026 |
| 482 |
ATRIAL FLUTTER |
21 |
0.0026 |
| 483 |
NEUROLOGICAL SYMPTOM |
15 |
0.0026 |
| 484 |
CHEST X-RAY ABNORMAL |
8 |
0.0026 |
| 485 |
ILEUS |
32 |
0.0026 |
| 486 |
BLOOD UREA INCREASED |
43 |
0.0026 |
| 487 |
SPINAL CORD COMPRESSION |
10 |
0.0026 |
| 488 |
OEDEMA |
139 |
0.0026 |
| 489 |
EPIGASTRIC DISCOMFORT |
10 |
0.0026 |
| 490 |
EMBOLIC STROKE |
9 |
0.0026 |
| 491 |
BLOOD CREATININE DECREASED |
8 |
0.0026 |
| 492 |
SQUAMOUS CELL CARCINOMA |
24 |
0.0025 |
| 493 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
45 |
0.0025 |
| 494 |
SKIN ABRASION |
12 |
0.0025 |
| 495 |
IRIDOCYCLITIS |
8 |
0.0025 |
| 496 |
SARCOIDOSIS |
12 |
0.0025 |
| 497 |
PEMPHIGOID |
19 |
0.0025 |
| 498 |
NECROSIS |
14 |
0.0025 |
| 499 |
FAILURE TO THRIVE |
13 |
0.0025 |
| 500 |
GUILLAIN-BARRE SYNDROME |
12 |
0.0025 |
| 501 |
PNEUMONIA |
802 |
0.0025 |
| 502 |
STEVENS-JOHNSON SYNDROME |
55 |
0.0025 |
| 503 |
BLOOD SODIUM DECREASED |
46 |
0.0024 |
| 504 |
HYPERURICAEMIA |
10 |
0.0024 |
| 505 |
LEUKOCYTOSIS |
44 |
0.0024 |
| 506 |
STRESS CARDIOMYOPATHY |
14 |
0.0024 |
| 507 |
CIRCULATORY COLLAPSE |
41 |
0.0024 |
| 508 |
PANCREATITIS ACUTE |
54 |
0.0024 |
| 509 |
DEEP VEIN THROMBOSIS |
156 |
0.0024 |
| 510 |
PROTEIN TOTAL DECREASED |
9 |
0.0024 |
| 511 |
CARDIOMYOPATHY |
35 |
0.0024 |
| 512 |
WHITE BLOOD CELL COUNT DECREASED |
256 |
0.0024 |
| 513 |
BACTERAEMIA |
28 |
0.0024 |
| 514 |
MYASTHENIA GRAVIS |
19 |
0.0024 |
| 515 |
ADVERSE REACTION |
31 |
0.0023 |
| 516 |
SHOCK HAEMORRHAGIC |
19 |
0.0023 |
| 517 |
EPISTAXIS |
174 |
0.0023 |
| 518 |
ANGIOPATHY |
13 |
0.0023 |
| 519 |
LYMPHOCYTE COUNT DECREASED |
41 |
0.0023 |
| 520 |
PULMONARY ALVEOLAR HAEMORRHAGE |
13 |
0.0023 |
| 521 |
ACUTE MYELOID LEUKAEMIA |
36 |
0.0023 |
| 522 |
GASTROINTESTINAL INFLAMMATION |
18 |
0.0023 |
| 523 |
RASH VESICULAR |
11 |
0.0023 |
| 524 |
DYSPNOEA EXERTIONAL |
85 |
0.0023 |
| 525 |
FACE OEDEMA |
38 |
0.0023 |
| 526 |
GLOSSITIS |
8 |
0.0023 |
| 527 |
BLOOD URIC ACID INCREASED |
13 |
0.0022 |
| 528 |
DIARRHOEA HAEMORRHAGIC |
21 |
0.0022 |
| 529 |
RESPIRATORY DISTRESS |
62 |
0.0022 |
| 530 |
NEUTROPHIL COUNT INCREASED |
23 |
0.0022 |
| 531 |
PANCREATIC DISORDER |
11 |
0.0022 |
| 532 |
NEUROTOXICITY |
39 |
0.0022 |
| 533 |
HYPOVOLAEMIA |
13 |
0.0022 |
| 534 |
PERITONITIS |
46 |
0.0022 |
| 535 |
SKIN REACTION |
31 |
0.0022 |
| 536 |
LIVER FUNCTION TEST INCREASED |
47 |
0.0022 |
| 537 |
SKIN DISORDER |
73 |
0.0022 |
| 538 |
DEHYDRATION |
289 |
0.0022 |
| 539 |
LOCALISED OEDEMA |
10 |
0.0022 |
| 540 |
PLATELET COUNT ABNORMAL |
13 |
0.0021 |
| 541 |
CARDIAC DYSFUNCTION |
8 |
0.0021 |
| 542 |
ARTERIOSCLEROSIS |
20 |
0.0021 |
| 543 |
PERIORBITAL SWELLING |
12 |
0.0021 |
| 544 |
VENTRICULAR EXTRASYSTOLES |
22 |
0.0021 |
| 545 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
60 |
0.0021 |
| 546 |
HYPOPHAGIA |
54 |
0.0021 |
| 547 |
OEDEMA PERIPHERAL |
257 |
0.0021 |
| 548 |
ATAXIA |
25 |
0.0021 |
| 549 |
GASTRIC ULCER |
40 |
0.0021 |
| 550 |
CARDIAC FAILURE ACUTE |
14 |
0.0021 |
| 551 |
FOLLICULITIS |
22 |
0.0021 |
| 552 |
DIABETIC KETOACIDOSIS |
50 |
0.0021 |
| 553 |
THYROID DISORDER |
32 |
0.0021 |
| 554 |
ACUTE MYOCARDIAL INFARCTION |
61 |
0.0021 |
| 555 |
BRONCHOPULMONARY ASPERGILLOSIS |
16 |
0.0021 |
| 556 |
SUBARACHNOID HAEMORRHAGE |
21 |
0.0021 |
| 557 |
ABNORMAL LOSS OF WEIGHT |
14 |
0.0021 |
| 558 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
51 |
0.0021 |
| 559 |
GASTRITIS |
54 |
0.0021 |
| 560 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
21 |
0.0020 |
| 561 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
47 |
0.0020 |
| 562 |
HYPERNATRAEMIA |
10 |
0.0020 |
| 563 |
PROTEIN URINE PRESENT |
10 |
0.0020 |
| 564 |
CEREBRAL INFARCTION |
49 |
0.0020 |
| 565 |
HYDRONEPHROSIS |
15 |
0.0020 |
| 566 |
HEPATIC FAILURE |
60 |
0.0020 |
| 567 |
GASTRIC ULCER HAEMORRHAGE |
11 |
0.0020 |
| 568 |
ASPERGILLUS INFECTION |
13 |
0.0020 |
| 569 |
HAEMODYNAMIC INSTABILITY |
15 |
0.0020 |
| 570 |
PYREXIA |
678 |
0.0020 |
| 571 |
FEMORAL NECK FRACTURE |
10 |
0.0019 |
| 572 |
THROMBOTIC MICROANGIOPATHY |
19 |
0.0019 |
| 573 |
MENINGITIS |
13 |
0.0019 |
| 574 |
ANAPHYLACTOID REACTION |
8 |
0.0019 |
| 575 |
SPINAL OSTEOARTHRITIS |
17 |
0.0019 |
| 576 |
AORTIC DISSECTION |
8 |
0.0019 |
| 577 |
ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS |
15 |
0.0019 |
| 578 |
MULTI-ORGAN FAILURE |
33 |
0.0019 |
| 579 |
ATRIAL FIBRILLATION |
184 |
0.0019 |
| 580 |
HAEMOGLOBIN DECREASED |
194 |
0.0019 |
| 581 |
ONYCHOCLASIS |
13 |
0.0019 |
| 582 |
BLOOD BILIRUBIN INCREASED |
51 |
0.0019 |
| 583 |
CONJUNCTIVITIS |
35 |
0.0019 |
| 584 |
CARDIAC FAILURE CHRONIC |
8 |
0.0019 |
| 585 |
LIVER DISORDER |
83 |
0.0019 |
| 586 |
LUNG INFECTION |
29 |
0.0019 |
| 587 |
LYMPHOPENIA |
26 |
0.0018 |
| 588 |
LYMPHADENOPATHY |
65 |
0.0018 |
| 589 |
DIVERTICULUM INTESTINAL |
8 |
0.0018 |
| 590 |
BODY TEMPERATURE DECREASED |
18 |
0.0018 |
| 591 |
ANAPHYLACTIC REACTION |
101 |
0.0018 |
| 592 |
FLUID INTAKE REDUCED |
9 |
0.0018 |
| 593 |
DERMATITIS EXFOLIATIVE |
9 |
0.0018 |
| 594 |
CLOSTRIDIUM DIFFICILE COLITIS |
19 |
0.0018 |
| 595 |
SKIN INFECTION |
20 |
0.0018 |
| 596 |
SUPRAVENTRICULAR TACHYCARDIA |
17 |
0.0018 |
| 597 |
ASTHENIA |
667 |
0.0018 |
| 598 |
STATUS EPILEPTICUS |
20 |
0.0018 |
| 599 |
GINGIVAL BLEEDING |
24 |
0.0018 |
| 600 |
CARDIAC FAILURE |
141 |
0.0018 |
| 601 |
VENTRICULAR TACHYCARDIA |
29 |
0.0018 |
| 602 |
VOMITING |
823 |
0.0017 |
| 603 |
SKIN HYPERPIGMENTATION |
15 |
0.0017 |
| 604 |
TRISMUS |
9 |
0.0017 |
| 605 |
HYPERBILIRUBINAEMIA |
18 |
0.0017 |
| 606 |
LYMPHOEDEMA |
12 |
0.0017 |
| 607 |
MELAENA |
38 |
0.0017 |
| 608 |
PETECHIAE |
18 |
0.0017 |
| 609 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
29 |
0.0017 |
| 610 |
CARPAL TUNNEL SYNDROME |
24 |
0.0017 |
| 611 |
NEPHROPATHY |
16 |
0.0017 |
| 612 |
NEUROPATHY PERIPHERAL |
162 |
0.0017 |
| 613 |
LIPASE INCREASED |
13 |
0.0017 |
| 614 |
COVID-19 PNEUMONIA |
20 |
0.0017 |
| 615 |
ACUTE CORONARY SYNDROME |
14 |
0.0017 |
| 616 |
BLOOD CALCIUM DECREASED |
19 |
0.0017 |
| 617 |
HEMIPLEGIA |
14 |
0.0017 |
| 618 |
DELIRIUM |
58 |
0.0017 |
| 619 |
DIVERTICULITIS |
46 |
0.0017 |
| 620 |
HYPERKALAEMIA |
58 |
0.0017 |
| 621 |
BRONCHIECTASIS |
11 |
0.0016 |
| 622 |
BLOOD DISORDER |
13 |
0.0016 |
| 623 |
DIARRHOEA |
1041 |
0.0016 |
| 624 |
DYSPHAGIA |
151 |
0.0016 |
| 625 |
CYANOSIS |
25 |
0.0016 |
| 626 |
KLEBSIELLA INFECTION |
8 |
0.0016 |
| 627 |
CONSTIPATION |
343 |
0.0016 |
| 628 |
LUNG NEOPLASM MALIGNANT |
64 |
0.0016 |
| 629 |
ORTHOSTATIC HYPOTENSION |
27 |
0.0015 |
| 630 |
DISEASE RECURRENCE |
73 |
0.0015 |
| 631 |
PLATELET COUNT INCREASED |
20 |
0.0015 |
| 632 |
REFUSAL OF TREATMENT BY PATIENT |
10 |
0.0015 |
| 633 |
HEPATOMEGALY |
15 |
0.0015 |
| 634 |
PNEUMONIA ASPIRATION |
38 |
0.0015 |
| 635 |
RASH |
662 |
0.0015 |
| 636 |
RENAL FAILURE ACUTE |
64 |
0.0015 |
| 637 |
EPILEPSY |
46 |
0.0015 |
| 638 |
PROTHROMBIN TIME PROLONGED |
9 |
0.0015 |
| 639 |
RED BLOOD CELL COUNT DECREASED |
43 |
0.0015 |
| 640 |
LUNG DISORDER |
73 |
0.0015 |
| 641 |
CELLULITIS |
75 |
0.0015 |
| 642 |
NAIL DISORDER |
13 |
0.0015 |
| 643 |
HYDROCEPHALUS |
8 |
0.0015 |
| 644 |
ENCEPHALOPATHY |
36 |
0.0015 |
| 645 |
GLOMERULAR FILTRATION RATE DECREASED |
18 |
0.0015 |
| 646 |
ACIDOSIS |
11 |
0.0014 |
| 647 |
ANAPHYLACTIC SHOCK |
37 |
0.0014 |
| 648 |
HYPERGLYCAEMIA |
52 |
0.0014 |
| 649 |
HEMIPARESIS |
24 |
0.0014 |
| 650 |
WHITE BLOOD CELL COUNT ABNORMAL |
9 |
0.0014 |
| 651 |
C-REACTIVE PROTEIN ABNORMAL |
9 |
0.0014 |
| 652 |
BRONCHOSPASM |
20 |
0.0014 |
| 653 |
GASTROINTESTINAL DISORDER |
125 |
0.0014 |
| 654 |
COGNITIVE DISORDER |
65 |
0.0014 |
| 655 |
GINGIVAL PAIN |
11 |
0.0014 |
| 656 |
METABOLIC DISORDER |
8 |
0.0014 |
| 657 |
HYPERCALCAEMIA |
17 |
0.0014 |
| 658 |
EYELID OEDEMA |
16 |
0.0014 |
| 659 |
FAECES SOFT |
10 |
0.0014 |
| 660 |
GENERALISED OEDEMA |
17 |
0.0014 |
| 661 |
GASTROENTERITIS |
20 |
0.0014 |
| 662 |
GROIN PAIN |
12 |
0.0014 |
| 663 |
IMMUNE SYSTEM DISORDER |
18 |
0.0014 |
| 664 |
ARTERIOSCLEROSIS CORONARY ARTERY |
9 |
0.0014 |
| 665 |
APPETITE DISORDER |
9 |
0.0014 |
| 666 |
MUSCULOSKELETAL CHEST PAIN |
21 |
0.0014 |
| 667 |
NAUSEA |
1072 |
0.0014 |
| 668 |
LOWER GASTROINTESTINAL HAEMORRHAGE |
10 |
0.0014 |
| 669 |
RESPIRATORY RATE INCREASED |
12 |
0.0014 |
| 670 |
HAEMATEMESIS |
34 |
0.0013 |
| 671 |
LUPUS-LIKE SYNDROME |
12 |
0.0013 |
| 672 |
HYPERTENSION |
278 |
0.0013 |
| 673 |
CENTRAL NERVOUS SYSTEM LESION |
18 |
0.0013 |
| 674 |
TACHYCARDIA |
116 |
0.0013 |
| 675 |
SKIN PLAQUE |
11 |
0.0013 |
| 676 |
WHITE BLOOD CELL COUNT INCREASED |
50 |
0.0013 |
| 677 |
UROSEPSIS |
12 |
0.0013 |
| 678 |
OFF LABEL USE |
1130 |
0.0013 |
| 679 |
THERAPY NON-RESPONDER |
58 |
0.0013 |
| 680 |
EJECTION FRACTION DECREASED |
20 |
0.0013 |
| 681 |
SPINAL PAIN |
15 |
0.0013 |
| 682 |
INFECTION |
184 |
0.0013 |
| 683 |
SINUS TACHYCARDIA |
18 |
0.0013 |
| 684 |
CYTOMEGALOVIRUS INFECTION |
21 |
0.0013 |
| 685 |
OXYGEN SATURATION DECREASED |
71 |
0.0013 |
| 686 |
VENTRICULAR FIBRILLATION |
14 |
0.0013 |
| 687 |
RENAL CYST |
10 |
0.0013 |
| 688 |
DYSPNOEA |
706 |
0.0012 |
| 689 |
DRUG INTOLERANCE |
120 |
0.0012 |
| 690 |
SKIN LESION |
34 |
0.0012 |
| 691 |
RASH PRURITIC |
67 |
0.0012 |
| 692 |
TOXICITY TO VARIOUS AGENTS |
207 |
0.0012 |
| 693 |
NEOPLASM |
14 |
0.0012 |
| 694 |
HAEMATURIA |
41 |
0.0012 |
| 695 |
ATRIOVENTRICULAR BLOCK COMPLETE |
8 |
0.0012 |
| 696 |
RENAL DISORDER |
55 |
0.0012 |
| 697 |
HEPATIC ENCEPHALOPATHY |
11 |
0.0012 |
| 698 |
PRODUCT USE IN UNAPPROVED INDICATION |
292 |
0.0012 |
| 699 |
APPENDICITIS |
11 |
0.0012 |
| 700 |
CHOLECYSTITIS |
14 |
0.0012 |
| 701 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
61 |
0.0012 |
| 702 |
HYPOTENSION |
233 |
0.0012 |
| 703 |
ANGINA PECTORIS |
33 |
0.0012 |
| 704 |
REBOUND EFFECT |
13 |
0.0011 |
| 705 |
NODULE |
15 |
0.0011 |
| 706 |
CARDIO-RESPIRATORY ARREST |
47 |
0.0011 |
| 707 |
DIPLOPIA |
29 |
0.0011 |
| 708 |
ORAL PAIN |
25 |
0.0011 |
| 709 |
MENTAL STATUS CHANGES |
31 |
0.0011 |
| 710 |
DYSGEUSIA |
82 |
0.0011 |
| 711 |
TACHYPNOEA |
15 |
0.0011 |
| 712 |
ACUTE HEPATIC FAILURE |
15 |
0.0011 |
| 713 |
ASPIRATION |
12 |
0.0011 |
| 714 |
MYOCLONUS |
13 |
0.0011 |
| 715 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
28 |
0.0011 |
| 716 |
TREATMENT FAILURE |
90 |
0.0011 |
| 717 |
CEREBRAL DISORDER |
8 |
0.0011 |
| 718 |
URINARY RETENTION |
36 |
0.0011 |
| 719 |
RECTAL HAEMORRHAGE |
46 |
0.0011 |
| 720 |
DYSARTHRIA |
40 |
0.0011 |
| 721 |
PANCREATITIS |
55 |
0.0010 |
| 722 |
DEVICE RELATED INFECTION |
16 |
0.0010 |
| 723 |
PYELONEPHRITIS |
9 |
0.0010 |
| 724 |
MYELODYSPLASTIC SYNDROME |
15 |
0.0010 |
| 725 |
SINUS BRADYCARDIA |
10 |
0.0010 |
| 726 |
DRUG INTERACTION |
164 |
0.0010 |
| 727 |
URINE OUTPUT DECREASED |
9 |
0.0010 |
| 728 |
DRUG TOXICITY |
14 |
0.0010 |
| 729 |
SYNCOPE |
101 |
0.0010 |
| 730 |
IMMUNODEFICIENCY |
15 |
0.0010 |
| 731 |
THROMBOSIS |
80 |
0.0010 |
| 732 |
FATIGUE |
772 |
0.0010 |
| 733 |
OPTIC NEURITIS |
9 |
0.0010 |
| 734 |
BLOOD POTASSIUM INCREASED |
16 |
0.0010 |
| 735 |
OCULAR DISCOMFORT |
11 |
0.0010 |
| 736 |
BONE PAIN |
57 |
0.0010 |
| 737 |
ERYTHEMA |
200 |
0.0010 |
| 738 |
ESCHERICHIA INFECTION |
8 |
0.0010 |
| 739 |
GENERALISED TONIC-CLONIC SEIZURE |
16 |
0.0010 |
| 740 |
LIVER FUNCTION TEST ABNORMAL |
28 |
0.0010 |
| 741 |
LACRIMATION INCREASED |
29 |
0.0010 |
| 742 |
CONDITION AGGRAVATED |
291 |
0.0010 |
| 743 |
SHOCK |
22 |
0.0010 |
| 744 |
CANDIDA INFECTION |
16 |
0.0009 |
| 745 |
COUGH |
264 |
0.0009 |
| 746 |
RASH ERYTHEMATOUS |
45 |
0.0009 |
| 747 |
ANOREXIA |
12 |
0.0009 |
| 748 |
CHROMATURIA |
21 |
0.0009 |
| 749 |
DEATH |
801 |
0.0009 |
| 750 |
ALTERED STATE OF CONSCIOUSNESS |
20 |
0.0009 |
| 751 |
GASTROINTESTINAL HAEMORRHAGE |
77 |
0.0009 |
| 752 |
CHRONIC KIDNEY DISEASE |
70 |
0.0009 |
| 753 |
BACK INJURY |
10 |
0.0009 |
| 754 |
EOSINOPHILIA |
16 |
0.0009 |
| 755 |
CARDIAC ARREST |
75 |
0.0009 |
| 756 |
PRODUCTIVE COUGH |
43 |
0.0009 |
| 757 |
THIRST |
16 |
0.0009 |
| 758 |
EYELID PTOSIS |
9 |
0.0009 |
| 759 |
MITRAL VALVE INCOMPETENCE |
10 |
0.0009 |
| 760 |
MOTOR DYSFUNCTION |
9 |
0.0009 |
| 761 |
PRESCRIBED OVERDOSE |
17 |
0.0009 |
| 762 |
SCAB |
10 |
0.0009 |
| 763 |
HAEMORRHAGE |
91 |
0.0009 |
| 764 |
DYSURIA |
32 |
0.0009 |
| 765 |
MUSCLE ATROPHY |
11 |
0.0009 |
| 766 |
TENDERNESS |
9 |
0.0009 |
| 767 |
MUSCULOSKELETAL PAIN |
45 |
0.0009 |
| 768 |
DIABETES MELLITUS |
65 |
0.0009 |
| 769 |
ABDOMINAL PAIN |
197 |
0.0008 |
| 770 |
COAGULOPATHY |
14 |
0.0008 |
| 771 |
ELECTROCARDIOGRAM QT PROLONGED |
30 |
0.0008 |
| 772 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
24 |
0.0008 |
| 773 |
PULMONARY THROMBOSIS |
9 |
0.0008 |
| 774 |
MUSCULAR WEAKNESS |
93 |
0.0008 |
| 775 |
ULCER |
13 |
0.0008 |
| 776 |
HYPERTENSIVE CRISIS |
9 |
0.0008 |
| 777 |
HEPATIC STEATOSIS |
15 |
0.0008 |
| 778 |
DYSPHONIA |
47 |
0.0008 |
| 779 |
RESPIRATORY DISORDER |
24 |
0.0008 |
| 780 |
DERMATITIS ALLERGIC |
10 |
0.0008 |
| 781 |
INFLAMMATION |
41 |
0.0008 |
| 782 |
LOWER RESPIRATORY TRACT INFECTION |
36 |
0.0008 |
| 783 |
CHEST PAIN |
146 |
0.0008 |
| 784 |
CONFUSIONAL STATE |
127 |
0.0008 |
| 785 |
WEIGHT DECREASED |
217 |
0.0008 |
| 786 |
PULMONARY HYPERTENSION |
16 |
0.0008 |
| 787 |
BLOOD POTASSIUM DECREASED |
23 |
0.0008 |
| 788 |
HYPERLIPIDAEMIA |
9 |
0.0008 |
| 789 |
DRUG INEFFECTIVE |
983 |
0.0007 |
| 790 |
JAUNDICE |
20 |
0.0007 |
| 791 |
MUSCLE TIGHTNESS |
12 |
0.0007 |
| 792 |
BLOOD URINE PRESENT |
14 |
0.0007 |
| 793 |
UVEITIS |
10 |
0.0007 |
| 794 |
NERVOUS SYSTEM DISORDER |
23 |
0.0007 |
| 795 |
SKIN ULCER |
19 |
0.0007 |
| 796 |
URINARY TRACT INFECTION |
125 |
0.0007 |
| 797 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
26 |
0.0007 |
| 798 |
CORONARY ARTERY OCCLUSION |
10 |
0.0007 |
| 799 |
STAPHYLOCOCCAL INFECTION |
24 |
0.0007 |
| 800 |
THERAPEUTIC RESPONSE DECREASED |
44 |
0.0007 |
| 801 |
SKIN FISSURES |
14 |
0.0007 |
| 802 |
PULMONARY OEDEMA |
32 |
0.0007 |
| 803 |
RENAL INJURY |
21 |
0.0007 |
| 804 |
COVID-19 |
123 |
0.0007 |
| 805 |
ANGIOEDEMA |
31 |
0.0007 |
| 806 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
12 |
0.0007 |
| 807 |
PRESYNCOPE |
17 |
0.0007 |
| 808 |
BACTERIAL INFECTION |
13 |
0.0007 |
| 809 |
CORONARY ARTERY DISEASE |
21 |
0.0007 |
| 810 |
TASTE DISORDER |
14 |
0.0007 |
| 811 |
UPPER RESPIRATORY TRACT INFECTION |
31 |
0.0007 |
| 812 |
RASH PAPULAR |
15 |
0.0007 |
| 813 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
26 |
0.0007 |
| 814 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
36 |
0.0007 |
| 815 |
DEAFNESS |
17 |
0.0006 |
| 816 |
PHARYNGEAL OEDEMA |
10 |
0.0006 |
| 817 |
VERTIGO |
39 |
0.0006 |
| 818 |
PRODUCT USE ISSUE |
120 |
0.0006 |
| 819 |
CEREBROVASCULAR ACCIDENT |
108 |
0.0006 |
| 820 |
SEIZURE |
73 |
0.0006 |
| 821 |
FLUSHING |
64 |
0.0006 |
| 822 |
POST PROCEDURAL COMPLICATION |
12 |
0.0006 |
| 823 |
PULMONARY ARTERIAL HYPERTENSION |
9 |
0.0006 |
| 824 |
HEPATIC ENZYME INCREASED |
42 |
0.0006 |
| 825 |
CHEST DISCOMFORT |
63 |
0.0006 |
| 826 |
ARRHYTHMIA |
29 |
0.0006 |
| 827 |
CHOLELITHIASIS |
20 |
0.0006 |
| 828 |
HERPES ZOSTER |
35 |
0.0006 |
| 829 |
OSTEOPOROSIS |
25 |
0.0006 |
| 830 |
BONE DISORDER |
11 |
0.0006 |
| 831 |
FUNGAL INFECTION |
20 |
0.0006 |
| 832 |
MYALGIA |
102 |
0.0006 |
| 833 |
HAEMATOCHEZIA |
33 |
0.0006 |
| 834 |
APHASIA |
18 |
0.0006 |
| 835 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
107 |
0.0006 |
| 836 |
BODY TEMPERATURE INCREASED |
12 |
0.0006 |
| 837 |
DELUSION |
9 |
0.0006 |
| 838 |
DRUG EFFECT INCOMPLETE |
21 |
0.0006 |
| 839 |
NEURALGIA |
14 |
0.0006 |
| 840 |
DEVICE OCCLUSION |
8 |
0.0006 |
| 841 |
OROPHARYNGEAL PAIN |
52 |
0.0006 |
| 842 |
HYPERSENSITIVITY |
104 |
0.0006 |
| 843 |
ECZEMA |
29 |
0.0006 |
| 844 |
ABDOMINAL PAIN LOWER |
14 |
0.0006 |
| 845 |
INTENTIONAL PRODUCT USE ISSUE |
48 |
0.0005 |
| 846 |
DRUG LEVEL INCREASED |
9 |
0.0005 |
| 847 |
BACK PAIN |
125 |
0.0005 |
| 848 |
PARAESTHESIA |
84 |
0.0005 |
| 849 |
MYOCARDIAL INFARCTION |
93 |
0.0005 |
| 850 |
METABOLIC ACIDOSIS |
17 |
0.0005 |
| 851 |
MALAISE |
233 |
0.0005 |
| 852 |
INTESTINAL OBSTRUCTION |
20 |
0.0005 |
| 853 |
PAIN IN JAW |
15 |
0.0005 |
| 854 |
BLOOD PRESSURE DECREASED |
35 |
0.0005 |
| 855 |
INTERNATIONAL NORMALISED RATIO INCREASED |
15 |
0.0005 |
| 856 |
MUSCULOSKELETAL DISCOMFORT |
9 |
0.0005 |
| 857 |
AGEUSIA |
13 |
0.0005 |
| 858 |
PRURITUS |
200 |
0.0005 |
| 859 |
RETCHING |
11 |
0.0005 |
| 860 |
VIRAL INFECTION |
17 |
0.0005 |
| 861 |
LABORATORY TEST ABNORMAL |
15 |
0.0005 |
| 862 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
11 |
0.0005 |
| 863 |
URINARY INCONTINENCE |
15 |
0.0005 |
| 864 |
ALOPECIA |
99 |
0.0005 |
| 865 |
UNRESPONSIVE TO STIMULI |
13 |
0.0005 |
| 866 |
CEREBRAL HAEMORRHAGE |
18 |
0.0005 |
| 867 |
HAEMATOMA |
13 |
0.0005 |
| 868 |
SPINAL FRACTURE |
10 |
0.0005 |
| 869 |
FLATULENCE |
28 |
0.0005 |
| 870 |
SLEEP APNOEA SYNDROME |
9 |
0.0005 |
| 871 |
BLINDNESS |
19 |
0.0005 |
| 872 |
RESTLESSNESS |
17 |
0.0005 |
| 873 |
DIZZINESS |
231 |
0.0005 |
| 874 |
SKIN EXFOLIATION |
39 |
0.0005 |
| 875 |
HAEMORRHOIDS |
9 |
0.0005 |
| 876 |
PRODUCT PRESCRIBING ISSUE |
10 |
0.0005 |
| 877 |
ABDOMINAL PAIN UPPER |
94 |
0.0005 |
| 878 |
ADVERSE DRUG REACTION |
41 |
0.0005 |
| 879 |
ADVERSE EVENT |
42 |
0.0005 |
| 880 |
BLOOD TRIGLYCERIDES INCREASED |
8 |
0.0005 |
| 881 |
CHILLS |
53 |
0.0005 |
| 882 |
BLOOD GLUCOSE ABNORMAL |
8 |
0.0004 |
| 883 |
OCULAR HYPERAEMIA |
20 |
0.0004 |
| 884 |
ARTHRITIS |
33 |
0.0004 |
| 885 |
JOINT STIFFNESS |
11 |
0.0004 |
| 886 |
HYPOACUSIS |
18 |
0.0004 |
| 887 |
POOR QUALITY SLEEP |
9 |
0.0004 |
| 888 |
TYPE 2 DIABETES MELLITUS |
14 |
0.0004 |
| 889 |
CLOSTRIDIUM DIFFICILE INFECTION |
9 |
0.0004 |
| 890 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
12 |
0.0004 |
| 891 |
BRONCHITIS |
30 |
0.0004 |
| 892 |
WHEEZING |
24 |
0.0004 |
| 893 |
DRY SKIN |
54 |
0.0004 |
| 894 |
NEOPLASM MALIGNANT |
27 |
0.0004 |
| 895 |
DISORIENTATION |
16 |
0.0004 |
| 896 |
RESPIRATORY ARREST |
11 |
0.0004 |
| 897 |
TINNITUS |
18 |
0.0004 |
| 898 |
TRANSIENT ISCHAEMIC ATTACK |
13 |
0.0004 |
| 899 |
ABDOMINAL DISTENSION |
40 |
0.0004 |
| 900 |
DRY MOUTH |
31 |
0.0004 |
| 901 |
COLITIS ULCERATIVE |
17 |
0.0004 |
| 902 |
COMA |
18 |
0.0004 |
| 903 |
SOMNOLENCE |
76 |
0.0004 |
| 904 |
BRADYCARDIA |
20 |
0.0004 |
| 905 |
NECK PAIN |
21 |
0.0004 |
| 906 |
FAECES DISCOLOURED |
8 |
0.0004 |
| 907 |
PALLOR |
10 |
0.0004 |
| 908 |
IMPAIRED HEALING |
12 |
0.0004 |
| 909 |
RHINORRHOEA |
23 |
0.0004 |
| 910 |
ARTHRALGIA |
146 |
0.0004 |
| 911 |
ERECTILE DYSFUNCTION |
9 |
0.0004 |
| 912 |
SKIN DISCOLOURATION |
16 |
0.0003 |
| 913 |
BALANCE DISORDER |
30 |
0.0003 |
| 914 |
DYSSTASIA |
10 |
0.0003 |
| 915 |
PAIN |
209 |
0.0003 |
| 916 |
BLISTER |
19 |
0.0003 |
| 917 |
FLUID RETENTION |
17 |
0.0003 |
| 918 |
LOCALISED INFECTION |
8 |
0.0003 |
| 919 |
HYPOGLYCAEMIA |
16 |
0.0003 |
| 920 |
ILL-DEFINED DISORDER |
19 |
0.0003 |
| 921 |
HEADACHE |
196 |
0.0003 |
| 922 |
LOSS OF CONSCIOUSNESS |
40 |
0.0003 |
| 923 |
RHABDOMYOLYSIS |
13 |
0.0003 |
| 924 |
MOVEMENT DISORDER |
10 |
0.0003 |
| 925 |
PALPITATIONS |
36 |
0.0003 |
| 926 |
SWELLING FACE |
20 |
0.0003 |
| 927 |
INFLUENZA |
34 |
0.0003 |
| 928 |
VISUAL IMPAIRMENT |
36 |
0.0003 |
| 929 |
CONVULSION |
16 |
0.0003 |
| 930 |
LETHARGY |
16 |
0.0003 |
| 931 |
OSTEONECROSIS |
9 |
0.0003 |
| 932 |
FALL |
90 |
0.0003 |
| 933 |
LIP SWELLING |
9 |
0.0003 |
| 934 |
RHEUMATOID ARTHRITIS |
30 |
0.0003 |
| 935 |
HYPERHIDROSIS |
34 |
0.0003 |
| 936 |
DISCOMFORT |
16 |
0.0003 |
| 937 |
BLOOD GLUCOSE INCREASED |
49 |
0.0003 |
| 938 |
FEMUR FRACTURE |
8 |
0.0003 |
| 939 |
RASH MACULAR |
9 |
0.0003 |
| 940 |
VISION BLURRED |
35 |
0.0003 |
| 941 |
DYSPEPSIA |
25 |
0.0003 |
| 942 |
MOBILITY DECREASED |
18 |
0.0003 |
| 943 |
JOINT SWELLING |
30 |
0.0002 |
| 944 |
SPEECH DISORDER |
13 |
0.0002 |
| 945 |
DEPRESSED MOOD |
13 |
0.0002 |
| 946 |
FEELING HOT |
15 |
0.0002 |
| 947 |
PAIN IN EXTREMITY |
70 |
0.0002 |
| 948 |
CARDIAC FAILURE CONGESTIVE |
19 |
0.0002 |
| 949 |
GASTROOESOPHAGEAL REFLUX DISEASE |
19 |
0.0002 |
| 950 |
BLOOD PRESSURE INCREASED |
35 |
0.0002 |
| 951 |
HEART RATE DECREASED |
8 |
0.0002 |
| 952 |
HOT FLUSH |
17 |
0.0002 |
| 953 |
GAIT DISTURBANCE |
43 |
0.0002 |
| 954 |
DISTURBANCE IN ATTENTION |
12 |
0.0002 |
| 955 |
WEIGHT INCREASED |
49 |
0.0002 |
| 956 |
NEPHROLITHIASIS |
10 |
0.0002 |
| 957 |
INSOMNIA |
58 |
0.0002 |
| 958 |
POLLAKIURIA |
9 |
0.0002 |
| 959 |
URTICARIA |
36 |
0.0002 |
| 960 |
ANXIETY |
61 |
0.0002 |
| 961 |
HEART RATE INCREASED |
21 |
0.0002 |
| 962 |
SKIN BURNING SENSATION |
15 |
0.0002 |
| 963 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
10 |
0.0002 |
| 964 |
VAGINAL HAEMORRHAGE |
9 |
0.0002 |
| 965 |
DEPRESSION |
47 |
0.0002 |
| 966 |
AGITATION |
15 |
0.0002 |
| 967 |
TREATMENT NONCOMPLIANCE |
11 |
0.0002 |
| 968 |
HYPOAESTHESIA |
30 |
0.0002 |
| 969 |
PSORIASIS |
24 |
0.0002 |
| 970 |
PERIPHERAL SWELLING |
28 |
0.0002 |
| 971 |
ARTHROPATHY |
10 |
0.0002 |
| 972 |
ACNE |
13 |
0.0002 |
| 973 |
INFLUENZA LIKE ILLNESS |
13 |
0.0002 |
| 974 |
SLEEP DISORDER |
11 |
0.0002 |
| 975 |
NASOPHARYNGITIS |
28 |
0.0002 |
| 976 |
CONTUSION |
14 |
0.0001 |
| 977 |
CATARACT |
8 |
0.0001 |
| 978 |
ABDOMINAL DISCOMFORT |
22 |
0.0001 |
| 979 |
HOSPITALISATION |
20 |
0.0001 |
| 980 |
OVERDOSE |
26 |
0.0001 |
| 981 |
HALLUCINATION |
9 |
0.0001 |
| 982 |
CARDIAC DISORDER |
11 |
0.0001 |
| 983 |
TREMOR |
19 |
0.0001 |
| 984 |
MUSCULOSKELETAL STIFFNESS |
10 |
0.0001 |
| 985 |
SINUSITIS |
11 |
0.0001 |
| 986 |
INTENTIONAL PRODUCT MISUSE |
9 |
0.0001 |
| 987 |
INCORRECT DOSE ADMINISTERED |
23 |
0.0001 |
| 988 |
NO ADVERSE EVENT |
16 |
0.0001 |
| 989 |
FEELING ABNORMAL |
21 |
0.0001 |
| 990 |
MEMORY IMPAIRMENT |
12 |
0.0001 |
| 991 |
ASTHMA |
9 |
0.0001 |
| 992 |
MUSCLE SPASMS |
14 |
0.0001 |
| 993 |
EMOTIONAL DISTRESS |
9 |
0.0001 |
| 994 |
PRODUCT DOSE OMISSION ISSUE |
17 |
0.0001 |